Tag: monoclonalantibody

• New Treatments For Bone Cancer

  Extensive efforts have been made recently to boost our understanding of the pathogenesis of bone cancer and develop therapeutic targets. This is an improvement since several decades ago; treatment protocols were medically challenged irrespective of their stage: bone sarcomas or metastasis of advanced cancers. There is a dire need for prompt treatment and critical attention.…

  thefarahsaeedtrust

  3rd Aug 2026

  Uncategorized

  absorption, allograft, alloplast, apoptosis, autograft, bioactiveglass, biocompatibility, biopsy, cancer, cell, chemiluminescence, chemotherapy, chromatin, denosumab, diffusion, dna, DNA replication, erlotinib, erythropoiesis, gallium, gene, haem, hypoxia, immobilization, inflammation, lenvatinib, levatonib, medicine, metastatic, monoclonalantibody, nanoparticles, oncology, osteoconductive, osteogenic, osteoinductive, parenteral, phagocytosis, photodynamictherapy, photoimmunotherapy, photon, photothermaltherapy, proton, radiation, reactiveoxygenspecies, regofarenib, sorafenib, surgery, targetedtherapy, xenoplast

• Targeted Therapy

  This is where a protein or enzyme is targeted to help prevent tumour growth and progression and boost the immune system. Several factors influence the type of targeted therapy: Clinical and medical history General Health Type of cancer Size of the cancer Previous cancer treatments for the cancer, whether new or recurring. The main types…

  thefarahsaeedtrust

  2nd Aug 2026

  Uncategorized

  bacteria, basophils, carboazatinib, cellsignalling, chemokines, cytokines, denosumab, enterocyte, enzyme, eosinophils, gene, imatinib, immune cell, inflammation, interleukins, lymphocytes, mifarmatide, monoclonalantibody, neutrophils, paneth, peyers, protein, proteinkinase, sorafenib, tumournecrosisfactor, tyrosinekinase